PlainRecalls
FDA Drug Low Class III Ongoing

Timolol Maleate Ophthalmic Solution, USP, 0.5%, 5 x 0.3 mL Single-Dose Vials, Rx Only, Sterile, Manufactured for: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-189-24

Reported: September 7, 2022 Initiated: August 8, 2022 #D-1471-2022

Product Description

Timolol Maleate Ophthalmic Solution, USP, 0.5%, 5 x 0.3 mL Single-Dose Vials, Rx Only, Sterile, Manufactured for: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-189-24

Reason for Recall

Identification of an unknown impurity at the 12-month stability point. Further investigation has identified the impurity as Timolol Phenol S-Oxide.

Details

Recalling Firm
Akorn, Inc
Units Affected
5,226 Cartons (60 vials/carton)
Distribution
Distributed Nationwide in the USA
Location
Gurnee, IL

Frequently Asked Questions

What product was recalled?
Timolol Maleate Ophthalmic Solution, USP, 0.5%, 5 x 0.3 mL Single-Dose Vials, Rx Only, Sterile, Manufactured for: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-189-24. Recalled by Akorn, Inc. Units affected: 5,226 Cartons (60 vials/carton).
Why was this product recalled?
Identification of an unknown impurity at the 12-month stability point. Further investigation has identified the impurity as Timolol Phenol S-Oxide.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 7, 2022. Severity: Low. Recall number: D-1471-2022.